Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1999;92(Suppl 37):41–49. doi: 10.1177/014107689909237s08

Update on intestinal strictures.

J M Littlewood 1
PMCID: PMC1297023  PMID: 10472252

Full text

PDF
41

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakowski M. T., Prescott P. Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis. Pharmacoepidemiol Drug Saf. 1997 Sep;6(5):347–358. doi: 10.1002/(SICI)1099-1557(199709/10)6:5<347::AID-PDS305>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  2. Beverley D. W., Kelleher J., MacDonald A., Littlewood J. M., Robinson T., Walters M. P. Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child. 1987 Jun;62(6):564–568. doi: 10.1136/adc.62.6.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borowitz D. S., Grand R. J., Durie P. R. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr. 1995 Nov;127(5):681–684. doi: 10.1016/s0022-3476(95)70153-2. [DOI] [PubMed] [Google Scholar]
  4. Bowler I. M., Wolfe S. P., Owens H. M., Sheldon T. A., Littlewood J. M., Walters M. P. A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis. Arch Dis Child. 1993 Feb;68(2):227–230. doi: 10.1136/adc.68.2.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crisci K. L., Greenberg S. B., Wolfson B. J., Geller E., Vinocur C. D. Contrast enema findings of fibrosing colonopathy. Pediatr Radiol. 1997 Apr;27(4):315–316. doi: 10.1007/s002470050136. [DOI] [PubMed] [Google Scholar]
  6. Croft N. M., Marshall T. G., Ferguson A. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet. 1995 Nov 11;346(8985):1265–1267. doi: 10.1016/s0140-6736(95)91864-7. [DOI] [PubMed] [Google Scholar]
  7. Dalzell A. M., Freestone N. S., Billington D., Heaf D. P. Small intestinal permeability and orocaecal transit time in cystic fibrosis. Arch Dis Child. 1990 Jun;65(6):585–588. doi: 10.1136/adc.65.6.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DiMagno E. P., Malagelada J. R., Go V. L., Moertel C. G. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med. 1977 Jun 9;296(23):1318–1322. doi: 10.1056/NEJM197706092962304. [DOI] [PubMed] [Google Scholar]
  9. FitzSimmons S. C., Burkhart G. A., Borowitz D., Grand R. J., Hammerstrom T., Durie P. R., Lloyd-Still J. D., Lowenfels A. B. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. 1997 May 1;336(18):1283–1289. doi: 10.1056/NEJM199705013361803. [DOI] [PubMed] [Google Scholar]
  10. Freiman J. P., FitzSimmons S. C. Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States. J Pediatr Gastroenterol Nutr. 1996 Feb;22(2):153–156. doi: 10.1097/00005176-199602000-00005. [DOI] [PubMed] [Google Scholar]
  11. Gow R., Bradbear R., Francis P., Shepherd R. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine. Lancet. 1981 Nov 14;2(8255):1071–1074. doi: 10.1016/s0140-6736(81)91276-9. [DOI] [PubMed] [Google Scholar]
  12. Green M. R., Southern K. W., Wolfe S. P., Littlewood J. M., Najmaldin A. S., Wyatt J. I. Colonic strictures in cystic fibrosis. Arch Dis Child. 1995 Feb;72(2):191–191. doi: 10.1136/adc.72.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Greif J., Schwarz Y., Sperber F., Jurgenson U. Benign cystic teratoma simulating organized empyema. Pediatr Pulmonol. 1997 Apr;23(4):310–313. doi: 10.1002/(sici)1099-0496(199704)23:4<310::aid-ppul9>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  14. Guarner L., Rodríguez R., Guarner F., Malagelada J. R. Fate of oral enzymes in pancreatic insufficiency. Gut. 1993 May;34(5):708–712. doi: 10.1136/gut.34.5.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Haber H. P., Benda N., Fitzke G., Lang A., Langenberg M., Riethmüller J., Stern M. Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls. Gut. 1997 Mar;40(3):406–411. doi: 10.1136/gut.40.3.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hasler W. L. Pancreatic enzymes and colonic strictures with cystic fibrosis: a case-control study. Gastroenterology. 1998 Mar;114(3):609–612. doi: 10.1016/s0016-5085(98)70549-9. [DOI] [PubMed] [Google Scholar]
  17. Häusler M., Meilicke R., Biesterfeld S., Heimann G. First adult patient with fibrosing colonopathy. Am J Gastroenterol. 1998 Jul;93(7):1171–1172. doi: 10.1111/j.1572-0241.1998.00355.x. [DOI] [PubMed] [Google Scholar]
  18. Jones R., Franklin K., Spicer R., Berry J. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet. 1995 Aug 19;346(8973):499–499. [PubMed] [Google Scholar]
  19. King S. J., Van Velzen D., Smyth R. L., Carty H., Heaf D. Strictures of the colon in cystic fibrosis. Clin Radiol. 1994 Jul;49(7):476–477. doi: 10.1016/s0009-9260(05)81745-3. [DOI] [PubMed] [Google Scholar]
  20. Knabe N., Zak M., Hansen A., Moesgaard J., Kvist N., Beck B., Damgaard K., Koch C. Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 1994 May 14;343(8907):1230–1230. doi: 10.1016/s0140-6736(94)92443-0. [DOI] [PubMed] [Google Scholar]
  21. Lee J., Ip W., Durie P. Is fibrosing colonopathy an immune mediated disease? Arch Dis Child. 1997 Jul;77(1):66–70. doi: 10.1136/adc.77.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Littlewood J. M. Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice. Postgrad Med J. 1996 Mar;72 (Suppl 2):S56–S62. [PubMed] [Google Scholar]
  23. Lowdon J., Goodchild M. C., Ryley H. C., Doull I. J. Maintenance of growth in cystic fibrosis despite reduction in pancreatic enzyme supplementation. Arch Dis Child. 1998 Apr;78(4):377–378. doi: 10.1136/adc.78.4.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mac Sweeney E. J., Oades P. J., Buchdahl R., Rosenthal M., Bush A. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet. 1995 Mar 25;345(8952):752–756. doi: 10.1016/s0140-6736(95)90639-8. [DOI] [PubMed] [Google Scholar]
  25. Morrison G., Morrison J. M., Redmond A. O., Byers C. A., McCracken K. J., Dodge J. A., Guilford S. A., Bowden M. W. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Aliment Pharmacol Ther. 1992 Oct;6(5):549–555. doi: 10.1111/j.1365-2036.1992.tb00569.x. [DOI] [PubMed] [Google Scholar]
  26. Oades P. J., Rosenthal M., Mac Sweeney E. J., Bush A. Subclinical colonic thickening. J R Soc Med. 1996;89 (Suppl 27):24–30. [PMC free article] [PubMed] [Google Scholar]
  27. Pawel B. R., de Chadarévian J. P., Franco M. E. The pathology of fibrosing colonopathy of cystic fibrosis: a study of 12 cases and review of the literature. Hum Pathol. 1997 Apr;28(4):395–399. doi: 10.1016/s0046-8177(97)90025-3. [DOI] [PubMed] [Google Scholar]
  28. Pettei M. J., Leonidas J. C., Levine J. J., Gorvoy J. D. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy. J Pediatr. 1994 Oct;125(4):587–589. doi: 10.1016/s0022-3476(94)70014-1. [DOI] [PubMed] [Google Scholar]
  29. Pohl M., Krackhardt B., Posselt H. G., Lembcke B. Ultrasound studies of the intestinal wall in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1997 Sep;25(3):317–320. doi: 10.1097/00005176-199709000-00014. [DOI] [PubMed] [Google Scholar]
  30. Ramsden W. H., Moya E. F., Littlewood J. M. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis. Arch Dis Child. 1998 Oct;79(4):339–343. doi: 10.1136/adc.79.4.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Reichard K. W., Vinocur C. D., Franco M., Crisci K. L., Flick J. A., Billmire D. F., Schidlow D. V., Weintraub W. H. Fibrosing colonopathy in children with cystic fibrosis. J Pediatr Surg. 1997 Feb;32(2):237–242. doi: 10.1016/s0022-3468(97)90186-x. [DOI] [PubMed] [Google Scholar]
  32. Schwarzenberg S. J., Wielinski C. L., Shamieh I., Carpenter B. L., Jessurun J., Weisdorf S. A., Warwick W. J., Sharp H. L. Cystic fibrosis-associated colitis and fibrosing colonopathy. J Pediatr. 1995 Oct;127(4):565–570. doi: 10.1016/s0022-3476(95)70113-3. [DOI] [PubMed] [Google Scholar]
  33. Seal S., McClean P., Walters M., Wolfe S. P., Harding M., Coward W., Littlewood J. M. Stable isotope studies of pancreatic enzyme release in vivo. Postgrad Med J. 1996 Mar;72 (Suppl 2):S37–S38. [PubMed] [Google Scholar]
  34. Shah A., Dinwiddie R., Madge S., Prescott P., Hudson G. High dose Nutrizym 22 in cystic fibrosis. Eur J Pediatr. 1993 Sep;152(9):763–764. doi: 10.1007/BF01953997. [DOI] [PubMed] [Google Scholar]
  35. Smyth R. L., Ashby D., O'Hea U., Burrows E., Lewis P., van Velzen D., Dodge J. A. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet. 1995 Nov 11;346(8985):1247–1251. doi: 10.1016/s0140-6736(95)91860-4. [DOI] [PubMed] [Google Scholar]
  36. Smyth R. L. Fibrosing colonopathy in cystic fibrosis. Arch Dis Child. 1996 May;74(5):464–468. doi: 10.1136/adc.74.5.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Smyth R. L., van Velzen D., Smyth A. R., Lloyd D. A., Heaf D. P. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 1994 Jan 8;343(8889):85–86. doi: 10.1016/s0140-6736(94)90817-6. [DOI] [PubMed] [Google Scholar]
  38. Soldan W., Henker J., Sprössig C. Sensitivity and specificity of quantitative determination of pancreatic elastase 1 in feces of children. J Pediatr Gastroenterol Nutr. 1997 Jan;24(1):53–55. doi: 10.1097/00005176-199701000-00013. [DOI] [PubMed] [Google Scholar]
  39. Stead R. J., Skypala I., Hodson M. E., Batten J. C. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation. Thorax. 1987 Jul;42(7):533–537. doi: 10.1136/thx.42.7.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Stevens J. C., Maguiness K. M., Hollingsworth J., Heilman D. K., Chong S. K. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. J Pediatr Gastroenterol Nutr. 1998 Jan;26(1):80–84. doi: 10.1097/00005176-199801000-00014. [DOI] [PubMed] [Google Scholar]
  41. Walters M. P., Kelleher J., Gilbert J., Littlewood J. M. Clinical monitoring of steatorrhoea in cystic fibrosis. Arch Dis Child. 1990 Jan;65(1):99–102. doi: 10.1136/adc.65.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Waters B. L. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes. Pediatr Dev Pathol. 1998 Jan-Feb;1(1):74–78. doi: 10.1007/s100249900009. [DOI] [PubMed] [Google Scholar]
  43. Zerin J. M., Kuhn-Fulton J., White S. J., Chong S. K., Stevens J. C., West K. W., Teitelbaum D. H., Nasr S. Z. Colonic strictures in children with cystic fibrosis. Radiology. 1995 Jan;194(1):223–226. doi: 10.1148/radiology.194.1.7997557. [DOI] [PubMed] [Google Scholar]
  44. van Velzen D., Ball L. M., Dezfulian A. R., Southgate A., Howard C. V. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J. 1996 Mar;72 (Suppl 2):S39–S51. [PubMed] [Google Scholar]
  45. van Velzen D. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet. 1995 Aug 19;346(8973):499–500. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES